SB AdvisoryApril 2, 2020 update: Keep up with the latest from Stony Brook about the coronavirus situation.  More information

Stony Brook Experts

an online search tool for members of the media to identify experts at Stony Brook

Search experts:


Browse experts:

View all departments View all topics View all experts Close
Frederick B. Gutman Neurosurgeon, Director, Neurosurgery Inpatient Service, Co-director, Neuro-Oncology Center of the Neurosciences Institute, Assistant Professor of Neurological Surgery and Orthopedics Neurological Surgery School of Medicine

Contact Information

080 Health Sciences Center

Stony Brook, 11794



Frederick Gutman has expertise in all areas of neurosurgery. He performed the first cortical mapping procedure at Stony Brook University Hospital, and Suffolk County’s first minimally invasive endoscopic procedure to treat a pituitary tumor. His practice includes the treatment of herniated discs, brain aneurysms, cervical spondylosis, spinal stenosis, and spinal and brain tumors. He is expert in the use of stereotactic radiosurgery and image-guided computer assisted surgery.


  • Medical School, Stony Brook School of Medicine
  • Residency, New York Medical College, Surgery
  • Residency, University of Miami/Jackson Memorial Hospital, Neurological Surgery

Research Grants

Award Start End Sponsor Type Amount Status
A Prospective, Multi-Centered, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Clazosentan in Reducing Vasospasm-Related Morbidity and All-Cause Mortality in Adult Patients with Aneuri 2009-03-16T00:00:00 2012-01-27T00:00:00 Actelion Pharmaceuticals Ltd Nonfederal 65250 Closed
Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intra-Cranial Pressure - the RESCUEicp Study 2011-12-01T00:00:00 2016-11-04T00:00:00 Chancellor Masters & Scholars of Univ of Cambridge of The Old Schools Nonfederal 1 Closed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parrallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury 2012-03-01T00:00:00 2015-12-08T00:00:00 Asubio Pharmaceuticals Incorporated Nonfederal 12618.13 Closed
A Double-Blind, Placebo-Controlled Study of AC105 in Patients with Acute Traumatic Spinal Cord Injury 2013-05-20T00:00:00 2016-09-20T00:00:00 Acorda Therapeutics Nonfederal 21156.25 Closed
A Phase III Clinical Trial Evaluating DCVax-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme (GBM) 2013-07-12T00:00:00 2017-12-07T00:00:00 Northwest Biotherapeutics Nonfederal 116895.2 Approved
Medtronic Product Surveillance Registry 2013-10-11T00:00:00 2018-06-06T00:00:00 Medtronic Incorporated Nonfederal 60301.1 Approved
A Phase II Study of Rindopepimut IGM-CSF in Patients with Relapsed EGFRvUI-Positive Glioblastoma (The ReACT Study) 2014-01-14T00:00:00 2017-01-22T00:00:00 Celldex Therapeutics Incorporated Nonfederal 26516.29 Closed
Vascular Biogenics: A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-Center Study of VB-111 Combined with Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma 2016-05-25T00:00:00 2018-09-04T00:00:00 PPD Investigator Services LLC Nonfederal 39309.01 Approved
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma (Toca 5) 2016-07-26T00:00:00 2018-03-22T00:00:00 Tocagen Incorporated Nonfederal 16875.66 Approved